These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1118989)
1. Acetohydroxamic acid. Potential use in urinary infection caused by urea-splitting bacteria. Griffith DP; Musher DM Urology; 1975 Mar; 05(3):299-302. PubMed ID: 1118989 [TBL] [Abstract][Full Text] [Related]
2. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. Griffith DP; Gibson JR; Clinton CW; Musher DM J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of urease as chemotherapeutic agents. Rosenstein IJ; Hamilton-Miller JM Crit Rev Microbiol; 1984; 11(1):1-12. PubMed ID: 6373150 [No Abstract] [Full Text] [Related]
4. Acetohydroxamate in struvite stones: in vivo study. Aroldi A; Graziani G; Castelnovo C; Colussi G; Surian M; Mandressi A; Mascheroni E; Pazardjiklian I; Pagano A; Ponticelli C Proc Eur Dial Transplant Assoc; 1983; 20():469-72. PubMed ID: 6657671 [TBL] [Abstract][Full Text] [Related]
5. [Urinary calculi and infection]. Trinchieri A Urologia; 2014; 81(2):93-8. PubMed ID: 24874306 [TBL] [Abstract][Full Text] [Related]
6. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Andersen JA Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613 [TBL] [Abstract][Full Text] [Related]
7. Disposition of 14C-acetohydroxamic acid and 14C-acetamide in the rat. Putcha L; Griffith DP; Feldman S Drug Metab Dispos; 1984; 12(4):438-43. PubMed ID: 6148210 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi. Putcha L; Griffith DP; Feldman S Eur J Clin Pharmacol; 1985; 28(4):439-45. PubMed ID: 3928387 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive chemotherapy of infection-induced staghorn calculi. Griffith DP; Moskowitz PA; Carlton CE Trans Am Assoc Genitourin Surg; 1978; 70():25-9. PubMed ID: 380109 [TBL] [Abstract][Full Text] [Related]
11. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. Griffith DP; Khonsari F; Skurnick JH; James KE J Urol; 1988 Aug; 140(2):318-24. PubMed ID: 3294442 [TBL] [Abstract][Full Text] [Related]
12. Infection stones and the role of bacterial urease. Rosenstein I; Hamilton-Miller JM; Brumfitt W J Infect; 1980 Sep; 2(3):211-4. PubMed ID: 6764484 [No Abstract] [Full Text] [Related]
18. Inhibition of urease by miscellaneous ions and compounds. Implications for the therapy of infection-induced urolithiasis. Burr RG Invest Urol; 1977 Sep; 15(2):180-2. PubMed ID: 903216 [TBL] [Abstract][Full Text] [Related]
19. Effect of acetohydroxamic acid on prevention of canine struvite uroliths. Krawiec DR; Osborne CA; Leininger JR; Griffith DP Am J Vet Res; 1984 Jul; 45(7):1276-82. PubMed ID: 24049883 [TBL] [Abstract][Full Text] [Related]
20. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid. Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]